Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00218387 · ClinicalTrials.gov registry record · Phase 2
Modafinil Combined With Cognitive Behavior Therapy to Treat Cocaine Addiction - 1
A Phase 2 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 2
- Development phase
- 123
- Enrollment target
NCT00218387 is a Phase 2 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 123 participants.
The verdict
NCT00218387, a Phase 2 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 123 participants
- Enrollment target
Study Summary
Cocaine addiction is a serious health problem with no available medical treatment for preventing relapse. Modafinil, a medication that enhances mood, increases energy, and improves concentration, may be useful in preventing relapse among individuals with cocaine addiction. This study will evaluate the effectiveness of modafinil, in combination with cognitive behavior therapy (CBT), to prevent drug relapse among cocaine addicts.
Interventions
- DRUG Modafinil
- DRUG Matching Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2004-04 |
| Est. Completion | 2010-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00218387
The ClinicalTrials.gov registry entry for NCT00218387 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 123 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Modafinil is the first listed.
NCT00218387 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00218387 about?
NCT00218387 is a clinical study titled "Modafinil Combined With Cognitive Behavior Therapy to Treat Cocaine Addiction - 1". Cocaine addiction is a serious health problem with no available medical treatment for preventing relapse. Modafinil, a medication that enhances mood, increases energy, and improves concentration, may be useful in preventing relapse among individuals with cocaine addiction. This study will evaluate t...
What is the current status of trial NCT00218387?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 123 participants. The study started on 2004-04. Estimated completion is 2010-07.
What interventions are being tested in trial NCT00218387?
The interventions under investigation include: Modafinil (DRUG), Matching Placebo (DRUG).
Who is sponsoring clinical trial NCT00218387?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.